Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marcella Marinelli Salvadori"'
Autor:
Nayra Soares do Amaral, Marcella Marinelli Salvadori, Glauco Baiocchi, Adriana Regina Gonçalves Ribeiro, Alexandre Andre Balieiro Anastacio da Costa, Andrea Paiva Gadelha Guimarães, Elizabeth Santana dos Santos, João Paulo da Nogueira Silveira Lima, Graziele Bovolim, Joyce Lisboa, Fabrício de Souza Castro, Mariana Rezende Alves, Henrique Mantoan, Ronaldo Pereira, Solange Moraes Sanches, Felipe Ilelis, Louise De Brot
Publikováno v:
Cancer Research. 79:3157-3157
Introduction: Bevacizumab is an antiangiogenic agent approved to treat ovarian cancer in combination to chemotherapy. The relative benefit of bevacizumab in ovarian cancer patients seems to be greater the more the disease becomes platinum resistant.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbbb7e1c97825979a117f7cc66abe095
https://doi.org/10.1158/1538-7445.am2019-3157
https://doi.org/10.1158/1538-7445.am2019-3157
Autor:
Alexandre Andre Balieiro Anastacio, da Costa, Camila V, Valadares, Henrique, Mantoan, Augusto, Saito, Marcella Marinelli, Salvadori, Andreia Paiva, Guimarães, Solange Moraes, Sanches, Maria Isabel Alves de Souza Wadington, Achatz, Glauco, Baiocchi
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 26(3)
Secondary cytoreductive surgery (SCS) is an option for treating patients with recurrent ovarian cancer. Three ongoing randomized trials are comparing SCS plus chemotherapy with chemotherapy alone, and few comparative studies have been published.We pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5bfc356bb4c0084a69c28cbc8f6d9c20
https://pubmed.ncbi.nlm.nih.gov/26825830
https://pubmed.ncbi.nlm.nih.gov/26825830